BREAST CANCER
![Foto de BREAST CANCER](/img/grupo.png)
![Foto de Universidad Católica de Valencia San Vicente Mártir](/img/noimage_org.png)
Universidad Católica de Valencia San Vicente Mártir
Valencia, EspañaPublications in collaboration with researchers from Universidad Católica de Valencia San Vicente Mártir (3)
2024
-
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study
Breast, Vol. 77
-
Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial
eClinicalMedicine, Vol. 71